13 results were returned
Gerard Hogan, Advocate General at the Court of Justice of the European Union (“CJEU”) recently delivered an opinion in the pending case between MSD Animal Health Innovation (“MSD”), Intervet international (“Intervet”) ...
In the last five decades we have been assisting on the digitalization of society and consequently of the healthcare sector; we have been using terms such as eHealth, medical informatics, health informatics, ...
The world's most popular banana is dying. Scientists are using the gene-editing mechanism CRISPR to try and save it from extinction.
On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation on Supplementary Protection Certificates ("SPCs").
So notes the Commission's report on competition enforcement in the pharmaceutical sector (2009-2017) published at the end of January 2019.
Sanofi sought a compulsory licence for the distribution of its high cholesterol drug Praluent® but this was dismissed in preliminary proceedings (docket no: 3 LiQ 1/18).
This new regime, applicable either to types of intangible assets or to a family of products or services, provides taxation at a reduced rate of 10% of net income generated by industrial property including patents and ...
The French Health Data Hub was born officially with the publication on 30 November 2019 of a ministerial decision (arrêté).
A majority postulates a new "outward presentation test" to deal with the infringement of second medical use patents.
The French so-called “anti-gift” provisions strictly frame the conditions under which companies in the health sector are allowed to provide advantages, in cash or in kind, to healthcare professionals ("HCPs”)